Further studies found that increased MIR17HG expression is associated with a poor prognosis in patients with diverse types of tumours30,31, and single-nucleotide polymorphisms of MIR17HG are associated with a risk of breast cancer development32. The gene discussed is MIR17HG; the disease is breast carcinoma.